NOX4 and cardiac hypertrophy: In transgenic mice subjected to TAC surgery (suprarenal banding) for 9 weeks, cardiac-specific overexpression of NOX4 was reported to preserve cardiac function and decrease cardiac hypertrophy and fibrosis, by increasing angiogenic markers expression and fatty acid oxidation [28,29] (Table 1).